论文部分内容阅读
乳腺癌的发生、发展是一个多因素、多阶段的复杂过程,涉及多个基因和多种分子水平。在肿瘤基因水平上寻找新的预后指标并开展靶向治疗已成为目前肿瘤研究的热点之一。近年来,针对Cerb-B2基因的分子靶向治疗药物——
The occurrence and development of breast cancer is a multi-factor, multi-stage and complex process involving multiple genes and various molecular levels. It is one of the hot topics in cancer research to find new prognostic indicators and to carry out targeted therapy at the tumor gene level. In recent years, the molecular targeted therapy for Cerb-B2 gene -